These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7386594)

  • 1. Redistribution of amyloid deposits.
    Shirahama T; Cohen AS
    Am J Pathol; 1980 Jun; 99(3):539-50. PubMed ID: 7386594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical AA amyloid deposits in bovine AA amyloidosis.
    Murakami T; Inoshima Y; Kobayashi Y; Matsui T; Inokuma H; Ishiguro N
    Amyloid; 2012 Mar; 19(1):15-20. PubMed ID: 22149364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis.
    Higuchi K; Naiki H; Kitagawa K; Hosokawa M; Takeda T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(4):231-8. PubMed ID: 1681611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
    Meek RL; Hoffman JS; Benditt EP
    J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster.
    Hol PR; Snel FW; Niewold TA; Gruys E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):273-81. PubMed ID: 2879382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical identification of amyloid in formalin-fixed paraffin sections.
    Shirahama T; Skinner M; Cohen AS
    Histochemistry; 1981; 72(2):161-71. PubMed ID: 7024214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic alveolar hydatidosis and secondary amyloidosis: pathological aspects of the disease in four strains of mice.
    Alkarmi TO; Ali-Khan Z
    Br J Exp Pathol; 1984 Aug; 65(4):405-17. PubMed ID: 6466552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amyloid transfer from a syngenous transplant of amyloid spleen in intact and amyloid mice].
    Sura VV; Osipova IN; Chebyshev AP; Serov VV; Gritsman AIu
    Biull Eksp Biol Med; 1978 Jun; 85(6):754-7. PubMed ID: 667351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine alveolar hydatidosis: a potential experimental model for the study of AA-amyloidosis.
    Ali-Khan Z; Jothy S; Al-Karmi T
    Br J Exp Pathol; 1983 Dec; 64(6):599-611. PubMed ID: 6661394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses.
    Cui D; Hoshii Y; Takahashi M; Kawano H; Iwata T; Ishihara T
    Pathol Int; 1998 May; 48(5):362-7. PubMed ID: 9704343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunomorphologic study of the early stages of amyloidogenesis].
    Kapinus LN
    Biull Eksp Biol Med; 1978 Feb; 85(2):232-4. PubMed ID: 343835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A primed state exists in vivo following histological regression of amyloidosis.
    Hawkins PN; Pepys MB
    Clin Exp Immunol; 1990 Aug; 81(2):325-8. PubMed ID: 2387095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AA-Amyloid is cleared by endogenous immunological mechanisms.
    Nyström SN; Westermark GT
    Amyloid; 2012 Sep; 19(3):138-45. PubMed ID: 22900541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient amyloid A clearance in the absence of immunoglobulins and complement factors.
    Sponarova J; Nuvolone M; Whicher C; Frei N; Kana V; Schwarz P; Westermark GT; Aguzzi A
    Am J Pathol; 2013 Apr; 182(4):1297-307. PubMed ID: 23454183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
    Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senile systemic amyloidosis.
    Pitkänen P; Westermark P; Cornwell GG
    Am J Pathol; 1984 Dec; 117(3):391-9. PubMed ID: 6507586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.